Bachrodt Amy sold MAZE
January 2, 2026 · Form 4 insider transaction
Bachrodt Amy sold 2,595 shares of Maze Therapeutics, Inc. at $39.57 per share, a transaction worth $102.7K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
2,595
Price
$39.57
Total value
$102.7K
InsiderBachrodt Amy
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJanuary 2, 2026
Filing dateJanuary 6, 2026
Shares owned after12,965
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.; The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.15 to $39.99 per share, inclusive.